Chrymutasin C

Chrymutasin C is a glycosidic antitumor antibiotic. Chrymutasin C is cytotoxic[1].

Product Specifications

CAS Number

[155232-80-7]

UNSPSC

12352005

Target

Antibiotic; Bacterial

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Cancer; Infection

Smiles

O=C1C(C2=C(OC(C3=C(C)C=CC4=C32)=O)C5=C(O[C@H]6[C@@H]([C@H]([C@H]([C@H](O6)C)O)O)O[C@@H]7[C@@H]([C@H]([C@H]([C@H](O7)C)O)O)O[C@@H]8[C@@H]([C@H]([C@H]([C@H](O8)C)O)OC)O)C=CC=C51)=C(N)C4=O

Molecular Formula

C39H43NO17

Molecular Weight

797.76

References & Citations

[1]H Uchida, et al. Chrymutasins: novel-aglycone antitumor antibiotics from a mutant of Streptomyces chartreusis. II. Characterization and structural elucidation. J Antibiot (Tokyo) . 1994 Jun;47 (6) :655-67.